Available in 12
locations and 7
The COVID-19 outbreak in the United States has wreaked havoc in the U.S. economy. In response, the U.S. government has taken massive actions to...
The Decisions has a significant impact on pharmaceutical companies.
China’s growing middle class and aging population is driving demand for improved health and aged care services and products.
The China-Australia FTA will come into force 20 December 2015, benefiting Australian & Chinese businesses.
China promulgated its first normative document on stem cell clinical research administration.
Accept and Close